Schizophrenia--Time to Commit to Policy Change

Journal of Clinical Psychiatry

(2018) · Journal of Clinical Psychiatry · doi:10.5505/kpd · Cited by 13,703 · see citing works

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888 · see citing works

Untitled work

(1996) · Cited by 6,884 · see citing works

Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892 · see citing works

Economic Costs of Diabetes in the U.S. in 2002

American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147 · see citing works

The size and burden of mental disorders and other disorders of the brain in Europe 2010

Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.018 · Cited by 3,754 · see citing works

What are the functional consequences of neurocognitive deficits in schizophrenia?

(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516 · see citing works

Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the ‘‘right stuff’’?

Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033430 · Cited by 2,999 · see citing works

Current Cigarette Smoking Among Adults — United States, 2005–2014

Jamal, A., Homa, D. M., O’Connor, E., Babb, S. D., Caraballo, R. S., Singh, T., Hu, S., & King, B. A. (2015) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6444a2 · Cited by 2,544 · see citing works

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care

DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488 · see citing works

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C., & Davis, J. M. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61764-x · Cited by 1,930 · see citing works

Cost of disorders of the brain in Europe 2010

Gustavsson, A., Svensson, M., Jacobi, F., Allgulander, C., Alonso, J., Beghi, E., Dodel, R., Ekman, M., Faravelli, C., Fratiglioni, L., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.08.008 · Cited by 1,723 · see citing works

A Meta-Analysis of Cognitive Remediation for Schizophrenia: Methodology and Effect Sizes

Wykes, T., Huddy, V., Cellard, C., McGurk, S. R., & Czobor, P. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10060855 · Cited by 1,693 · see citing works

Clozapine Treatment for Suicidality in Schizophrenia<subtitle>International Suicide Prevention Trial (InterSePT)</subtitle>

Meltzer, H. Y. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.82 · Cited by 1,393 · see citing works

A Meta-Analysis of Cognitive Remediation in Schizophrenia

McGurk, S. R., Twamley, E. W., Sitzer, D. I., McHugo, G. J., & Mueser, K. T. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07060906 · Cited by 1,214 · see citing works

Global pattern of experienced and anticipated discrimination against people with schizophrenia: a cross-sectional survey

Thornicroft, G., Brohan, E., Rose, D. S., Sartorius, N., & Leese, M. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61817-6 · Cited by 1,189 · see citing works

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

Kahn, R. S., Fleischhacker, W. W., Boter, H., Davidson, M., Vergouwe, Y., Keet, I. P., Gheorghe, M. D., Rybakowski, J. K., Galderisi, S., Libiger, J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60486-9 · Cited by 1,088 · see citing works

Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

Jones, P., Barnes, T., Davies, L., Dunn, G., Lloyd, H., Hayhurst, K. P., Murray, R., Markwick, A., & Lewis, S. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.10.1079 · Cited by 1,060 · see citing works

Recovery from psychotic illness: A 15- and 25-year international follow-up study

Harrison, G. L., Hopper, K. J., Craig, T., LASKA, E. M., Siegel, C., WANDERLING, J. A., Dubé, K. C., Ganev, K., Giel, R., der Heiden, W. A., et al. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.178.6.506 · Cited by 1,030 · see citing works

. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor.

Wykes, T., Steel, C., Everitt, B., & Tarrier, N. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm114 · Cited by 1,029 · see citing works

A Systematic Review and Meta-Analysis of Recovery in Schizophrenia

Jääskeläinen, E., Juola, P., Hirvonen, N., McGrath, J. J., Saha, S., Isohanni, M. K., Veijola, J. M., & Miettunen, J. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs130 · Cited by 909 · see citing works

The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements

Buchanan, R. W., Kreyenbuhl, J. A., Kelly, D. L., Noel, J. M., Boggs, D. L., Fischer, B. A., Himelhoch, S. S., Fang, B., Peterson, E. L., Aquino, P. R., et al. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp116 · Cited by 901 · see citing works

Duration of psychosis and outcome in first-episode schizophrenia

Loebel, A. D., Lieberman, J. A., Alvir, J. M., Mayerhoff, D. I., Geisler, S. H., & Szymanski, S. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.9.1183 · Cited by 880 · see citing works

Models of Community Care for Severe Mental Illness: A Review of Research on Case Management

Mueser, K. T., Bond, G. R., Drake, R. E., & Resnick, S. G. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033314 · Cited by 859 · see citing works

The Vermont longitudinal study of persons with severe mental illness, II: Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia

Harding, C. M., Brooks, G. W., Ashikaga, T., Strauss, J. S., & Breier, A. F. (1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.6.727 · Cited by 853 · see citing works

Review: Suicide and schizophrenia: a systematic review of rates and risk factors

Hor, K., & Taylor, M. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810385490 · Cited by 853 · see citing works

Comprehensive mental health action plan 2013–2020

Saxena, S., Funk, M. K., & Chisholm, D. (2015) · Eastern Mediterranean Health Journal · doi:10.26719/2015.21.7.461 · Cited by 831 · see citing works

The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements

Dixon, L. B., Dickerson, F., Bellack, A. S., Bennett, M., Dickinson, D., Goldberg, R. W., Lehman, A., Tenhula, W. N., Calmes, C., Pasillas, R. M., et al. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp115 · Cited by 774 · see citing works

One hundred years of schizophrenia: a meta-analysis of the outcome literature

Hegarty, J. D., Baldessarini, R. J., Tohen, M. F., WATERNAUX, C. M., & Oepen, G. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.10.1409 · Cited by 760 · see citing works

Family intervention for schizophrenia

Pharoah, F., Mari, J., Rathbone, J., & Wong, W. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000088.pub2 · Cited by 737 · see citing works

Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London

Chang, C.-K., Hayes, R. D., Perera, G., Broadbent, M. T. M., Fernandes, A. C., Lee, W. E., Hotopf, M., & Stewart, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019590 · Cited by 714 · see citing works

Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis

Rummel‐Kluge, C., Komossa, K., Schwarz, S., Hunger, H., Schmid, F., Lobos, C. A., Kissling, W., Davis, J. M., & Leucht, S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.07.012 · Cited by 679 · see citing works

Natural Course of Schizophrenic Disorders: A 15-Year Followup of a Dutch Incidence Cohort

Wiersma, D., Nienhuis, F. J., Slooff, C. J., & Giel, R. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033315 · Cited by 649 · see citing works

The Effect of Family Interventions on Relapse and Rehospitalization in Schizophrenia--A Meta-analysis

Pitschel-Walz, G., Leucht, S., Bäuml, J., Kissling, W., & Engel, R. R. (2001) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006861 · Cited by 647 · see citing works

Physical illness and schizophrenia: a review of the literature

Leucht, S., Burkard, T., Henderson, J., Maj, M., & Sartorius, N. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01095.x · Cited by 633 · see citing works

Effectiveness of Second-Generation Antipsychotics in Patients With Treatment-Resistant Schizophrenia: A Review and Meta-Analysis of Randomized Trials

Chakos, M., Lieberman, J. A., Hoffman, E. B., Bradford, D. W., & Sheitman, B. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.4.518 · Cited by 632 · see citing works

Convention on the Rights of Persons with Disabilities and Optional Protocol

States, M. (2012) · Cited by 630 · see citing works

The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.

Velligan, D. I., Weiden, P. J., Sajatovic, M., Scott, J. L., Carpenter, D., Ross, R., & Docherty, J. P. (2009) · PubMed · Cited by 625 · see citing works

Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study

Crump, C., Winkleby, M. A., Sundquist, K., & Sundquist, J. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12050599 · Cited by 619 · see citing works

The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis

Craig, T., Garety, P. A., Power, P., Rahaman, N., Colbert, S., Fornells‐Ambrojo, M., & Dunn, G. (2004) · BMJ · doi:10.1136/bmj.38246.594873.7c · Cited by 616 · see citing works

The Economic Burden of Schizophrenia in the United States in 2002

Wu, E. Q., Birnbaum, H. G., Shi, L., BALL, D. E., Kessler, R. C., Moulis, M., & Aggarwal, J. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0906 · Cited by 614 · see citing works

The effectiveness of supported employment for people with severe mental illness: a randomised controlled trial

Burns, T., Catty, J., Becker, T., Drake, R. E., Fioritti, A., Knapp, M., Lauber, C., Rössler, W., Tomov, T., van Busschbach, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61516-5 · Cited by 613 · see citing works

Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology

Barnes, T. R. E., Drake, R., Paton, C., Cooper, S. J., Deakin, J. F. W., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I. R., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 607 · see citing works

A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness

Petersen, L., Jeppesen, P., Thorup, A. A. E., Abel, M.-B., Øhlenschlæger, J., Christensen, T. Ø., Krarup, G., Jørgensen, P., & Nordentoft, M. (2005) · BMJ · doi:10.1136/bmj.38565.415000.e01 · Cited by 599 · see citing works

Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents

Miyamoto, S., Miyake, N., Jarskog, L. F., Fleischhacker, W. W., & Lieberman, J. A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.47 · Cited by 576 · see citing works

Drug and Sociotherapy in the Aftercare of Schizophrenic Patients

Hogarty, G. E. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760170005001 · Cited by 573 · see citing works

Scientific and Consumer Models of Recovery in Schizophrenia: Concordance, Contrasts, and Implications

Bellack, A. S. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj044 · Cited by 573 · see citing works

Physical health disparities and mental illness: the scandal of premature mortality

Thornicroft, G. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.092718 · Cited by 573 · see citing works

Multiple-Family Groups and Psychoeducation in the Treatment of Schizophrenia

McFarlane, W. R. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950200069016 · Cited by 559 · see citing works

Life expectancy among persons with schizophrenia or bipolar affective disorder

Laursen, T. M. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.06.008 · Cited by 508 · see citing works

Diet, smoking and cardiovascular risk in people with schizophrenia

McCreadie, R. G., & Scottish Schizophrenia Lifestyle Group (2003) · The British Journal of Psychiatry · doi:10.1192/bjp.183.6.534 · Cited by 494 · see citing works

A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia

Leucht, S., Komossa, K., Rummel‐Kluge, C., Corves, C., Hunger, H., Schmid, F., Lobos, C. A., Schwarz, S., & Davis, J. M. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08030368 · Cited by 489 · see citing works

Medication Adherence and Long-Term Functional Outcomes in the Treatment of Schizophrenia in Usual Care

Ascher‐Svanum, H., Faries, D. E., Zhu, B., Ernst, F. R., Swartz, M. S., & Swanson, J. W. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0317 · Cited by 485 · see citing works

Economic Costs of Diabetes in the U.S. in 2002Preprint

Dall, T. M., Nikolov, P., & Hogan, P. F. (2003) · RePEc: Research Papers in Economics · Cited by 483 · see citing works

The nature of relapse in schizophrenia

Emsley, R. A., Chiliza, B., Asmal, L., & Harvey, B. H. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-50 · Cited by 481 · see citing works

Barriers to Employment for People With Schizophrenia

Rosenheck, R., Leslie, D., Keefe, R., McEvoy, J., Swartz, M., Perkins, D., Stroup, S., Hsiao, J. K., Lieberman, J., & CATIE Study Investigators Group (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.3.411 · Cited by 465 · see citing works

The Environment and Schizophrenia: The Role of Cannabis Use

Henquet, C. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi027 · Cited by 448 · see citing works

Global pattern of experienced and anticipated discrimination reported by people with major depressive disorder: a cross-sectional survey

Lasalvia, A., Zoppei, S., Van Bortel, T., Bonetto, C., Cristofalo, D., Wahlbeck, K., Bacle, S. V., Van Audenhove, C., van Weeghel, J., Reneses, B., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61379-8 · Cited by 445 · see citing works

A Meta-Analysis of Controlled Research on Social Skills Training for Schizophrenia

Kurtz, M. M., & Mueser, K. T. (2008) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.76.3.491 · Cited by 425 · see citing works

Randomized Controlled Trial of Effect of Prescription of Clozapine Versus Other Second-Generation Antipsychotic Drugs in Resistant Schizophrenia

Lewis, S. W., Barnes, T. R. E., Davies, L. M., Murray, R. M., Dunn, G., Hayhurst, K. P., Markwick, A., Lloyd, H. M., & Jones, P. B. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj067 · Cited by 422 · see citing works

Psychosocial Treatments for Schizophrenia

Mueser, K. T., Deavers, F. E., Penn, D. L., & Cassisi, J. E. (2013) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185620 · Cited by 406 · see citing works

Efficacy of Psychological Therapy in Schizophrenia: Conclusions From Meta-analyses

Pfammatter, M. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl030 · Cited by 398 · see citing works

Long-Acting Injectable vs Oral Antipsychotics for Relapse Prevention in Schizophrenia: A Meta-Analysis of Randomized Trials

Kishimoto, T., Robenzadeh, A., Leucht, C., Leucht, S., Watanabe, K., Mimura, M., Borenstein, M., Kane, J. M., & Correll, C. U. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs150 · Cited by 395 · see citing works

Diet, smoking and cardiovascular risk in people with schizophrenia

McCreadie, R. G., & Scottish Schizophrenia Lifestyle Group (2003) · The British Journal of Psychiatry · doi:10.1192/03-162 · Cited by 392 · see citing works

Generalizability of the Individual Placement and Support (IPS) model of supported employment outside the US

Bond, G. R., Drake, R. E., & Becker, D. R. (2012) · World Psychiatry · doi:10.1016/j.wpsyc.2012.01.005 · Cited by 360 · see citing works

Neuroprotective Effects of Cognitive Enhancement Therapy Against Gray Matter Loss in Early Schizophrenia: Results From a 2-Year Randomized Controlled Trial

Eack, S. M., Hogarty, G. E., Cho, R. Y., Prasad, K. M. R., Greenwald, D. P., Hogarty, S. S., & Keshavan, M. S. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.63 · Cited by 360 · see citing works

Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology

Barnes, T. R. E. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110391123 · Cited by 357 · see citing works

Involving users in the delivery and evaluation of mental health services: systematic review

Simpson, E. L., & House, A. O. (2002) · BMJ · doi:10.1136/bmj.325.7375.1265 · Cited by 350 · see citing works

Mental Health and the Global Agenda

Becker, A. E., & Kleinman, A. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1110827 · Cited by 348 · see citing works

The Myth of Schizophrenia as a Progressive Brain Disease

Zipursky, R. B., Reilly, T. J., & Murray, R. M. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs135 · Cited by 336 · see citing works

Multifamily Groups in the Treatment of Severe Psychiatric Disorders

McFarlane, W. R. (2002) · Medical Entomology and Zoology · Cited by 335 · see citing works

Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices

Mitchell, A. J., Delaffon, V., Vancampfort, D., Correll, C. U., & De Hert, M. (2012) · Psychological Medicine · doi:10.1017/s003329171100105x · Cited by 332 · see citing works

Cognitive Effects of Antipsychotic Drugs in First-Episode Schizophrenia and Schizophreniform Disorder: A Randomized, Open-Label Clinical Trial (EUFEST)

Davidson, M., Galderisi, S., Weiser, M., Werbeloff, N., Fleischhacker, W., Keefe, R. S. E., Boter, H., Keet, I. P. M., Prelipceanu, D., RYBAKOWSKI, J. K., et al. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08060806 · Cited by 320 · see citing works

Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia

Morken, G., Widen, J. H., & Gråwe, R. W. (2008) · BMC Psychiatry · doi:10.1186/1471-244x-8-32 · Cited by 299 · see citing works

Rethinking social recovery in schizophrenia: what a capabilities approach might offer

Hopper, K. (2007) · Social Science & Medicine · doi:10.1016/j.socscimed.2007.04.012 · Cited by 296 · see citing works

Maintenance treatment with antipsychotic drugs for schizophrenia

Leucht, S., Tardy, M., Komossa, K., Heres, S., Kissling, W., & Davis, J. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008016.pub2 · Cited by 287 · see citing works

A Trial of Family Therapy v. a Relatives Group for Schizophrenia

Leff, J., Berkowitz, R., Shavit, N., STRACHAN, A. M., Glass, I. B., & Vaughn, C. E. (1989) · The British Journal of Psychiatry · doi:10.1192/bjp.154.1.58 · Cited by 287 · see citing works

Treatment of substance abusing patients with comorbid psychiatric disorders

Kelly, T. M., Daley, D. C., & Douaihy, A. B. (2011) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.09.010 · Cited by 283 · see citing works

Systematic Review of Early Cardiometabolic Outcomes of the First Treated Episode of Psychosis

Foley, D. L., & Morley, K. I. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2 · Cited by 283 · see citing works

Results of a Randomized Controlled Trial of Mental Illness Self-management Using Wellness Recovery Action Planning

Cook, J. Α., Copeland, M. E., Jonikas, J. A., Hamilton, M. M., Razzano, L. A., Grey, D. D., Floyd, C. B., Hudson, W. B., Macfarlane, R. T., Carter, T. M., et al. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr012 · Cited by 274 · see citing works

Death rate from ischaemic heart disease in Western Australian psychiatric patients 1980–1998

Lawrence, D. M., D'Arcy, C., Holman, J., Jablensky, A. V., & Hobbs, M. S. T. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.1.31 · Cited by 269 · see citing works

Psychosocial Treatments to Promote Functional Recovery in Schizophrenia

Kern, R. S., Glynn, S. M., Horan, W. P., & Marder, S. R. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn177 · Cited by 268 · see citing works

Recovery from schizophrenia and the recovery model

Warner, R. (2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32832c920b · Cited by 263 · see citing works

The Effectiveness of Assertive Community Treatment for Homeless Populations With Severe Mental Illness: A Meta-Analysis

Coldwell, C. M., & Bender, W. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.3.393 · Cited by 261 · see citing works

Do Patients with Schizophrenia Ever Show Periods of Recovery? A 15-Year Multi-Follow-up Study

Harrow, M. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi026 · Cited by 252 · see citing works

Economic Impacts of Assertive Community Treatment: A Review of the Literature

Latimer, E. A. (1999) · The Canadian Journal of Psychiatry · doi:10.1177/070674379904400504 · Cited by 251 · see citing works

The Numbers Count: Mental Disorders in America

(2013) · PsycEXTRA Dataset · doi:10.1037/e647522010-001 · Cited by 246 · see citing works

Smoking cessation in severe mental illness: what works?

Banham, L., & Gilbody, S. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.02946.x · Cited by 243 · see citing works

A review of the literature on the effectiveness of housing and support, assertive community treatment, and intensive case management interventions for persons with mental illness who have been homeless.

Nelson, G. B., Aubry, T., & Lafrance, A. (2007) · American Journal of Orthopsychiatry · doi:10.1037/0002-9432.77.3.350 · Cited by 235 · see citing works

Psychoeducational Multiple Family Groups: Four‐Year Relapse Outcome in Schizophrenia

McFarlane, W. R., Link, B. G., Dushay, R. A., MARCHAL, J., & Crilly, J. F. (1995) · Family Process · doi:10.1111/j.1545-5300.1995.00127.x · Cited by 234 · see citing works

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment

Lewis, S. W., Davies, L. M., Jones, P. B., Barnes, T. R. E., Murray, R. M., Kerwin, R. W., Taylor, D. M., Hayhurst, K. P., Markwick, A., Lloyd, H. M., et al. (2006) · Health Technology Assessment · doi:10.3310/hta10170 · Cited by 233 · see citing works

What Predicts a Good Response to Cognitive Remediation Interventions?

Medalia, A. A. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi045 · Cited by 226 · see citing works

Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia.

Leucht, S., & Heres, S. (2006) · PubMed · Cited by 226 · see citing works

Time trends in schizophrenia mortality in Stockholm county, Sweden: cohort study

Osby, U. (2000) · BMJ · doi:10.1136/bmj.321.7259.483 · Cited by 220 · see citing works

Initiatives to Promote the Discovery of Drugs to Improve Cognitive Function in Severe Mental Illness

Marder, S. R. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.0706e03 · Cited by 218 · see citing works

Burden of disease

Andrews, G., Sanderson, K. A., & Beard, J. (1998) · The British Journal of Psychiatry · doi:10.1192/bjp.173.2.123 · Cited by 218 · see citing works

Psychiatrists’ attitude towards and knowledge of clozapine treatment

Nielsen, J., Dahm, M., Lublin, H., & Taylor, D. M. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108100320 · Cited by 214 · see citing works

Risk of symptom recurrence with medication discontinuation in first-episode psychosis: A systematic review

Zipursky, R. B., Menezes, N. M., & Streiner, D. L. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.08.001 · Cited by 211 · see citing works

Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia

Swanson, J. W., Swartz, M. S., Dorn, R. A. V., Volavka, J., Monahan, J. T., Stroup, T. S., McEvoy, J. P., Wagner, H. R., Elbogen, E. B., & Lieberman, J. A. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.042630 · Cited by 201 · see citing works

The Key to Reducing Duration of Untreated First Psychosis: Information Campaigns

Joa, I., Johannessen, J. O., Auestad, B. H., Friis, S., McGlashan, T. H., Melle, I. S., Opjordsmoen, S., Simonsen, E. H., Vaglum, P. W., & Larsen, T. K. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm095 · Cited by 201 · see citing works

Individual placement and support for individuals with recent-onset schizophrenia: Integrating supported education and supported employment.

Nuechterlein, K. H., Subotnik, K. L., Turner, L. R., Ventura, J., Becker, D. R., & Drake, R. E. (2008) · Psychiatric Rehabilitation Journal · doi:10.2975/31.4.2008.340.349 · Cited by 200 · see citing works

Brain Effects of Cognitive Remediation Therapy in Schizophrenia: A Structural and Functional Neuroimaging Study

Penadés, R., Pujol, N., Catalán, R., Massana, G., Rametti, G., García‐Rizo, C., Bargalló, N., Gastó, C., Bernardo, M., & Junqué, C. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.017 · Cited by 196 · see citing works

The treatment of cognitive impairment in schizophrenia

GOFF, D. C., Hill, M. B., & Barch, D. M. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.11.009 · Cited by 196 · see citing works

Paradigms Lost: Fighting Stigma and the Lessons Learned

Stuart, H. L. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199797639.001.0001 · Cited by 195 · see citing works

Prior Antipsychotic Prescribing in Patients Currently Receiving Clozapine

Taylor, D. M., Young, C., & Paton, C. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0107 · Cited by 193 · see citing works

Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study

Harrow, M., Jobe, T. H., & Faull, R. N. (2012) · Psychological Medicine · doi:10.1017/s0033291712000220 · Cited by 192 · see citing works

First onset and early symptomatology of schizophrenia

Häfner, H., Riecher‐Rössler, A., Maurer, K., Fätkenheuer, B., & Löffler, W. (1992) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02191557 · Cited by 189 · see citing works

Randomized Trial of Critical Time Intervention to Prevent Homelessness After Hospital Discharge

Herman, D. B., Conover, S., Gorroochurn, P., Hinterland, K., Hoepner, L., & Susser, E. (2011) · Psychiatric Services · doi:10.1176/ps.62.7.pss6207_0713 · Cited by 189 · see citing works

A Trial of Family Therapy versus a Relatives' Group for Schizophrenia

Leff, J., Berkowitz, R., Shavit, N., STRACHAN, A. M., Glass, I. B., & Vaughn, C. (1990) · The British Journal of Psychiatry · doi:10.1192/bjp.157.4.571 · Cited by 184 · see citing works

Improving access to psychological therapies

Wild, S. (2007) · Independent Nurse · doi:10.12968/indn.2007.1.5.74836 · Cited by 183 · see citing works

Functional impairment in people with schizophrenia: Focus on employability and eligibility for disability compensation

Harvey, P. D., Heaton, R. K., Carpenter, W. T., Green, M. F., Gold, J. M., & Schoenbaum, M. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.03.025 · Cited by 173 · see citing works

Cognitive Behavior Therapy Versus Other Psychosocial Treatments for Schizophrenia

Jones, C., Hacker, D., Cormac, I., Meaden, A., & Irving, C. B. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs090 · Cited by 172 · see citing works

The impact of substance use disorders on the course of schizophrenia—A 15-year follow-up study

Schmidt, L. M., Hesse, M., & Lykke, J. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.04.011 · Cited by 171 · see citing works

Effect of early intervention on 5-year outcome in non-affective psychosis

Gafoor, R., Nitsch, D., McCrone, P., Craig, T., Garety, P. A., Power, P., & McGuire, P. K. (2010) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.109.066050 · Cited by 168 · see citing works

Science and Recovery in Schizophrenia

Lieberman, J. A., Drake, R. E., Sederer, L. I., Belger, A., Keefe, R. S. E., Perkins, D. O., & Stroup, T. S. (2008) · Psychiatric Services · doi:10.1176/ps.2008.59.5.487 · Cited by 168 · see citing works

Social Inclusion of People with Mental Illness

Leff, J., & Warner, R. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543937 · Cited by 164 · see citing works

Does the Therapeutic Relationship Predict Outcomes of Psychiatric Treatment in Patients with Psychosis? A Systematic Review

Priebe, S., Richardson, M. A., Cooney, M., Adedeji, O., & McCabe, R. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000320976 · Cited by 161 · see citing works

Rates and predictors of remission and recovery during 3 years in 392 never‐treated patients with schizophrenia

Lambert, M., Naber, D., Schacht, A., Wagner, T., Hundemer, H. P., Karow, A., Huber, C. G., Suarez, D. L., Haro, J. M., Novick, D., et al. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01213.x · Cited by 159 · see citing works

Outcomes of a Randomized Study of a Peer-Taught Family-to-Family Education Program for Mental Illness

Dixon, L. B., Lucksted, A. A., Medoff, D. R., Burland, J., Stewart, B., Lehman, A. F., Fang, L., Sturm, V., Brown, C., & Murray-Swank, A. B. (2011) · Psychiatric Services · doi:10.1176/ps.62.6.pss6206_0591 · Cited by 153 · see citing works

Predicting relapse after a first episode of non-affective psychosis: A three-year follow-up study

Caseiro, O., Pérez‐Iglesias, R., Mata, I. F., Martínez‐García, O., Pelayo‐Terán, J. M., Tabarés‐Seisdedos, R., de la Foz, V. O., Vázquez‐Barquero, J. L., & Crespo‐Facorro, B. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.05.001 · Cited by 150 · see citing works

Understanding how clinician-patient relationships and relational continuity of care affect recovery from serious mental illness: STARS study results.

Green, C. A., Polen, M. R., Janoff, S. L., Castleton, D. K., Wisdom, J. P., Vuckovic, N. H., Perrin, N., Paulson, R. I., & Oken, S. L. (2008) · Psychiatric Rehabilitation Journal · doi:10.2975/32.1.2008.9.22 · Cited by 139 · see citing works

Subjective and Objective Indicators of Recovery in Severe Mental Illness: a Cross-Sectional Study

Lloyd, C., King, R., & Moore, L. (2009) · International Journal of Social Psychiatry · doi:10.1177/0020764009105703 · Cited by 138 · see citing works

Outcomes of public concern in schizophrenia

Kooyman, I., Dean, K., Harvey, S. B., & Walsh, E. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.191.50.s29 · Cited by 138 · see citing works

The Therapeutic Relationship and Adherence to Antipsychotic Medication in Schizophrenia

McCabe, R., Bullenkamp, J., Hansson, L. I., Lauber, C., Martínez‐Leal, R., Wulf Rössler, A., Salize, H. J., Svensson, B., Torres‐González, F., van den Brink, R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036080 · Cited by 136 · see citing works

Duration of untreated psychosis and social function: 1-year follow-up study of first-episode schizophrenia

Barnes, T. R. E., Leeson, V. C., Mutsatsa, S. H., Watt, H., Hutton, S. B., & Joyce, E. M. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.108.049718 · Cited by 136 · see citing works

Supported housing for people with severe mental disorders

Chilvers, R., Macdonald, G. M., & Hayes, A. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000453.pub2 · Cited by 130 · see citing works

Recovery from schizophrenia

Warner, R. (2010) · Taylor & Francis eBooks · doi:10.4324/9780203420874_chapter_3 · Cited by 129 · see citing works

The cost of schizophrenia in Japan

Sado, M., Inagaki, A., Koreki, A., Knapp, M. R. J., Kissane, L. A., Mimura, & Yoshimura, K. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s41632 · Cited by 128 · see citing works

A Systematic Review of the Soteria Paradigm for the Treatment of People Diagnosed With Schizophrenia

Calton, T. G., Ferriter, M., Huband, N., & Spandler, H. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm047 · Cited by 126 · see citing works

Integrated care in schizophrenia: a 2‐year randomized controlled study of two community‐based treatment programs

Malm, U., Ivarsson, B., Alle­beck, P., & Falloon, I. R. H. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2003.00085.x · Cited by 123 · see citing works

Sexual Dysfunction in First-Episode Schizophrenia Patients

Malík, P., Kemmler, G., Hummer, M., Riecher‐Rössler, A., Kahn, R. S., & Fleischhacker, W. W. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182199bcc · Cited by 115 · see citing works

Supported employment: cost‐effectiveness across six European sites

Knapp, M. R. J., Patel, A. K., Curran, C., Latimer, E. A., Catty, J., Becker, T. M., Drake, R. E., Fioritti, A., Kilian, R., Lauber, C., et al. (2013) · World Psychiatry · doi:10.1002/wps.20017 · Cited by 114 · see citing works

Revascularisation and mortality rates following acute coronary syndromes in people with severe mental illness: comparative meta-analysis

Mitchell, A. J., & Lawrence, D. M. (2011) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.109.076950 · Cited by 111 · see citing works

Does Long-Term Treatment of Schizophrenia With Antipsychotic Medications Facilitate Recovery?

Harrow, M., & Jobe, T. H. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt034 · Cited by 106 · see citing works

Relationships Among Spirituality, Religious Practices, Personality Factors, and Health for Five Different Faith Traditions

Johnstone, B., Yoon, D. P., Cohen, D., Schopp, L. H., McCormack, G. L., Campbell, J., & Smith, M. L. (2012) · Journal of Religion and Health · doi:10.1007/s10943-012-9615-8 · Cited by 106 · see citing works

Cigarette smoking and schizophrenia

Kelly, C., & McCreadie, R. G. (2000) · Advances in Psychiatric Treatment · doi:10.1192/apt.6.5.327 · Cited by 104 · see citing works

Fighting schizophrenia and its stigma

Sartorius, N. (1997) · The British Journal of Psychiatry · doi:10.1192/bjp.170.4.297 · Cited by 99 · see citing works

Time to Change

Suzuki, D. T. (1993) · Cited by 97 · see citing works

Reducing the burden of side effects during long-term antipsychotic therapy: the role of "switching" medications.

Weiden, P. J., & Buckley, P. F. (2007) · PubMed · Cited by 92 · see citing works

Disparities in Hospitalization for Diabetes Among Persons With and Without Co-occurring Mental Disorders

Sullivan, G., Han, X., Moore, S. M., & Kotrla, K. J. (2006) · Psychiatric Services · doi:10.1176/ps.2006.57.8.1126 · Cited by 91 · see citing works

Mental disorders and vulnerability to homicidal death: Swedish nationwide cohort study

Crump, C., Sundquist, K., Winkleby, M. A., & Sundquist, J. (2013) · BMJ · doi:10.1136/bmj.f557 · Cited by 90 · see citing works

Attention Shaping: a Reward-Based Learning Method to Enhance Skills Training Outcomes in Schizophrenia

Silverstein, S. M., Spaulding, W. D., Menditto, A. A., Savitz, A. J., Liberman, R. P., Berten, S., & Starobin, H. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm150 · Cited by 89 · see citing works

Assertive community treatment across the Atlantic: comparison of model fidelity in the UK and USA

Fiander, M., Burns, T., McHugo, G. J., & Drake, R. E. (2003) · The British Journal of Psychiatry · doi:10.1192/bjp.182.3.248 · Cited by 89 · see citing works

Personalisation through Individual Budgets: Does It Work and for Whom?

Netten, A., Jones, K. M., Knapp, M. R. J., Fernández, J., Challis, D., Glendinning, C., Jacobs, S., Manthorpe, J., Moran, N. E., Stevens, M., et al. (2011) · The British Journal of Social Work · doi:10.1093/bjsw/bcr159 · Cited by 86 · see citing works

Clozapine for Treatment-Resistant Schizophrenia: National Institute of Clinical Excellence (NICE) Guidance in the Real World

Mortimer, A. M., Singh, P., Shepherd, C., & Puthiryackal, J. (2010) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.4.1.4 · Cited by 85 · see citing works

Anticipated discrimination among people with schizophrenia

Üçok, A., Brohan, E., Rose, D. S., Sartorius, N., Leese, M., Yoon, C., Plooy, A., Ertekin, B. A., Milev, R. V., Thornicroft, G., et al. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01772.x · Cited by 84 · see citing works

Outcomes of Critical Time Intervention Case Management of Homeless Veterans After Psychiatric Hospitalization

Kasprow, W. J., & Rosenheck, R. A. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.7.929 · Cited by 84 · see citing works

Randomised clinical trial comparing oral versus depot formulations of zuclopenthixol in patients with schizophrenia and previous violence

Arango, C., Bombín, I., González-Salvador, T., García‐Cabeza, I., & Bobes, J. (2005) · European Psychiatry · doi:10.1016/j.eurpsy.2005.07.006 · Cited by 82 · see citing works

Patient outcomes in schizophrenia I: correlates with sociodemographic variables, psychopathology, and side effects

Hofer, A., Baumgartner, S., Edlinger, M., Hummer, M., Kemmler, G., Rettenbacher, M. A., Schweigkofler, H., Schwitzer, J., & Fleischhacker, W. W. (2005) · European Psychiatry · doi:10.1016/j.eurpsy.2005.02.005 · Cited by 81 · see citing works

Monitoring and Managing Weight Gain in the Mentally Ill

Ganguli, R., Vreeland, B., & Newcomer, J. W. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.0607e14 · Cited by 81 · see citing works

Needs-based cognitive-behavioural family intervention for carers of patients suffering from schizophrenia: 12-month follow-up

Sellwood, W., Barrowclough, C., Tarrier, N., Quinn, J., Mainwaring, J., & Lewis, S. W. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00502.x · Cited by 79 · see citing works

Understanding and addressing adherence issues in schizophrenia: from theory to practice.

Weiden, P. J. (2007) · PubMed · Cited by 77 · see citing works

Recovery from schizophrenia : an international perspective : a report from the WHO collaborative project, the international study of schizophrenia

Hopper, K. J. (2007) · Cited by 77 · see citing works

Progress in Defining Optimal Treatment Outcome in Schizophrenia

Remington, G. J., Foussias, G., & Agid, O. (2009) · CNS Drugs · doi:10.2165/11530250-000000000-00000 · Cited by 77 · see citing works

Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: a quality improvement programme

Barnes, T. R. E., Paton, C., Hancock, E., Cavanagh, M.-R., Taylor, D. M., Lelliott, P. T., & Health, O. B. O. T. U. P. O. F. M. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01203.x · Cited by 75 · see citing works

Non-Specific Aspects of Treatment

Sartorius, E. B. M. S. N. (1989) · Cited by 75 · see citing works

Does Participation in Psychosocial Treatment Augment the Benefit of Clozapine?

Rosenheck, R. A. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.7.618 · Cited by 73 · see citing works

The Concept of "Being in Recovery".

Roe, D., Rudnick, A., & Gill, K. J. (2007) · Psychiatric Rehabilitation Journal · doi:10.2975/30.3.2007.171.173 · Cited by 69 · see citing works

Cost-Effectiveness of 12-Month Therapeutic Assertive Community Treatment as Part of Integrated Care Versus Standard Care in Patients With Schizophrenia Treated With Quetiapine Immediate Release (ACCESS Trial)

Karow, A., Reimer, J., König, H. H., Heider, D., Bock, T. A., Huber, C. G., Schöttle, D., Meister, K., Rietschel, L., Ohm, G., et al. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m06875 · Cited by 68 · see citing works

The European Schizophrenia Cohort

Bebbington, P., Angermeyer, M. C., Azorin, J., Brugha, T. S., Kilian, R., Johnson, S., Toumi, M., & Kornfeld, A. (2005) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-005-0955-5 · Cited by 67 · see citing works

Cognitive remediation therapy in schizophrenia: Cost-effectiveness analysis

Patel, A. K., Knapp, M. R. J., Romeo, R., Reeder, C., Matthíasson, P., Everitt, B. J., & Wykes, T. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2009.12.003 · Cited by 66 · see citing works

Effectiveness of Criminal Justice Liaison and Diversion Services for Offenders With Mental Disorders: A Review

Scott, D. A., McGilloway, S., Dempster, M., Browne, F., & Donnelly, M. (2013) · Psychiatric Services · doi:10.1176/appi.ps.201200144 · Cited by 63 · see citing works

Social Support and Religion: Mental Health Service Use and Treatment of Schizophrenia

Smolak, A., Gearing, R. E., Alonzo, D. M., Baldwin, S., Harmon, S. L., & McHugh, K. (2012) · Community Mental Health Journal · doi:10.1007/s10597-012-9536-8 · Cited by 61 · see citing works

Treatment of Tobacco Dependence in People With Mental Health and Addictive Disorders

Mackowick, K. M., Lynch, M.-J., Weinberger, A. H., & George, T. P. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0299-2 · Cited by 59 · see citing works

Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia

Ascher‐Svanum, H., Nyhuis, A. W., Faries, D. E., BALL, D. E., & Kinon, B. J. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-11 · Cited by 58 · see citing works

Costs of Criminal Justice Involvement Among Persons With Serious Mental Illness in Connecticut

Swanson, J. W., Frisman, L. K., Robertson, A. G., Lin, H., Trestman, R. L., Shelton, D., Parr, K., Rodis, E., Buchanan, A. W., & Swartz, M. S. (2013) · Psychiatric Services · doi:10.1176/appi.ps.002212012 · Cited by 58 · see citing works

Early intervention for first-episode psychosis: broadening the scope of economic estimates

Park, A., McCrone, P., & Knapp, M. (2016) · Early Intervention in Psychiatry · doi:10.1111/eip.12149 · Cited by 57 · see citing works

The Effectiveness of Assertive Community Treatment for Homeless Populations With Severe Mental Illness: A Meta-Analysis

Coldwell, C. M. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.164.3.393 · Cited by 57 · see citing works

Maintenance therapy and the natural course of schizophrenia.

Davis, J. M. (1985) · PubMed · Cited by 56 · see citing works

Diagnostic Procedures, Revascularization, and Inpatient Mortality After Acute Myocardial Infarction in Patients With Schizophrenia and Bipolar Disorder

Wu, S., Chen, S., Juang, J. J., Fang, C., Liu, S., Sun, F., Kao, K., Dewey, M. E., Prince, M. J., & Stewart, R. J. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31827612a6 · Cited by 55 · see citing works

The Individual Placement and Support approach to vocational rehabilitation for young people with first episode psychosis in the UK

Rinaldi, M., Perkins, R. E., McNeil, K., Hickman, N., & Singh, S. P. (2010) · Journal of Mental Health · doi:10.3109/09638230903531100 · Cited by 54 · see citing works

Nidotherapy: making the environment do the therapeutic work

Tyrer, P., & Bajaj, P. (2005) · Advances in Psychiatric Treatment · doi:10.1192/apt.11.3.232 · Cited by 54 · see citing works

Assertive Community Treatment in the Netherlands: Outcome and Model Fidelity

van Vugt, M. D., Kroon, H., Delespaul, P., Dreef, F. G., Nugter, A., Roosenschoon, B.-J., van Weeghel, J., Zoeteman, J. B., & Mulder, C. L. (2011) · The Canadian Journal of Psychiatry · doi:10.1177/070674371105600305 · Cited by 52 · see citing works

Development of a short measure of psychological recovery in serious mental illness: the STORI-30

Andresen, R., Caputi, P., & Oades, L. G. (2013) · Australasian Psychiatry · doi:10.1177/1039856213476352 · Cited by 51 · see citing works

Law & Psychiatry: What Can We Say About Mental Health Courts Today?

Goodale, G., Callahan, L. A., & Steadman, H. J. (2013) · Psychiatric Services · doi:10.1176/appi.ps.201300049 · Cited by 48 · see citing works

Is antipsychotic medication stigmatizing for people with mental illness?

Sajatovic, M., & JENKINS, J. H. (2007) · International Review of Psychiatry · doi:10.1080/09540260701278911 · Cited by 48 · see citing works

Associations of homelessness and residential mobility with length of stay after acute psychiatric admission

Tulloch, A., Khondoker, M., Fearon, P., & David, A. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-121 · Cited by 47 · see citing works

Effective Interventions in schizophrenia: the economic case.

Andrew, A., Knapp, M. R. J., McCrone, P., Parsonage, M., & Trachtenberg, M. (2012) · London School of Economics and Political Science Research Online (London School of Economics and Political Science) · Cited by 46 · see citing works

Psycho-education and family treatment related to the phase of a psychotic disorder

Goldstein, M. J. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199605002-00013 · Cited by 45 · see citing works

Multifamily Group Psychoeducation and Cognitive Remediation for First-Episode Psychosis: A Randomized Controlled Trial

Breitborde, N. J., Moreno, F. A., Mai-Dixon, N., Peterson, R., Durst, L., Bernstein, B., Byreddy, S., & McFarlane, W. R. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-9 · Cited by 45 · see citing works

Therapeutic Alliance and Improvements in Work Performance Over Time in Patients With Schizophrenia

Davis, L. W., & Lysaker, P. H. (2007) · The Journal of Nervous and Mental Disease · doi:10.1097/01.nmd.0000261954.36030.a1 · Cited by 43 · see citing works

The costs of schizophrenia and predictors of hospitalisation from the statutory health insurance perspective

Zeidler, J., Slawik, L., Fleischmann, J., & Greiner, W. (2012) · Health Economics Review · doi:10.1186/2191-1991-2-9 · Cited by 43 · see citing works

The Three R's Rehabilitation Program: A prevention approach for the management of relapse symptoms associated with psychiatric diagnoses.

Moller, M. D., & Murphy, M. F. (1997) · Psychiatric Rehabilitation Journal · doi:10.1037/h0095365 · Cited by 40 · see citing works

Peers and Peer-Led Interventions for People with Schizophrenia

Ahmed, A. O., Doane, N. J., Mabe, P. A., Buckley, P. F., Birgenheir, D. G., & Goodrum, N. M. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2012.06.009 · Cited by 39 · see citing works

A Comparative Study on the Cost of New Antibiotics and Drugs of Other Therapeutic Categories

Falagas, M. E., Fragoulis, K. N., & Karydis, I. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000011 · Cited by 35 · see citing works

Does Additional Care Provided by a Consumer Self-Help Group Improve Psychiatric Outcome? A Study in an Italian Community-based Psychiatric Service

Burti, L., Amaddeo, F., Ambrosi, M., Bonetto, C., Cristofalo, D., Ruggeri, M., & Tansella, M. (2005) · Community Mental Health Journal · doi:10.1007/s10597-005-6428-1 · Cited by 35 · see citing works

Mental health in an age of austerity

Knapp, M. R. J. (2012) · Evidence-Based Mental Health · doi:10.1136/ebmental-2012-100758 · Cited by 35 · see citing works

Needs‐based cognitive‐behavioural family intervention for patients suffering from schizophrenia: 5‐year follow‐up of a randomized controlled effectiveness trial

Sellwood, W., Wittkowski, A., Tarrier, N., & Barrowclough, C. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01097.x · Cited by 35 · see citing works

Economic Grand Rounds: Financing First-Episode Psychosis Services in the United States

Goldman, H. H., Karakus, M. C., Frey, W. D., & Beronio, K. K. (2013) · Psychiatric Services · doi:10.1176/appi.ps.201300106 · Cited by 34 · see citing works

Mental Health Disability

Drake, R. E., Bond, G. R., Thornicroft, G., Knapp, M. R. J., & Goldman, H. H. (2011) · Journal of Disability Policy Studies · doi:10.1177/1044207311427403 · Cited by 34 · see citing works

Characteristics of Adults With Serious Mental Illness in the United States Household Population in 2007

Pratt, L. A. (2012) · Psychiatric Services · doi:10.1176/appi.ps.201100442 · Cited by 34 · see citing works

Care and management of cardiovascular risk factors among individuals with schizophrenia and type 2 diabetes who smoke

Himelhoch, S. S., Leith, J. E., Goldberg, R. W., Kreyenbuhl, J. A., Medoff, D. R., & Dixon, L. B. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2008.07.007 · Cited by 32 · see citing works

Clinical outcome of assertive community treatment (ACT) in a rural area in Denmark: A case–control study with a 2-year follow-up

Aagaard, J., & Müller-Nielsen, K. (2010) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2010.544405 · Cited by 30 · see citing works

Housing Status as an Independent Predictor of Functional Capacity in Patients With Schizophrenia

Stergiopoulos, V., Burra, T. A., Rourke, S. B., & Hwang, S. W. (2011) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e3182349cfc · Cited by 30 · see citing works

Physical illness and schizophrenia

Kumar, C. T. S. (2004) · The British Journal of Psychiatry · doi:10.1192/bjp.184.6.541 · Cited by 28 · see citing works

ANOSOGNOSIA IN INDIVIDUALS WITH SCHIZOPHRENIA: TOWARD RECOVERY OF INSIGHT

Rickelman, B. L. (2004) · Issues in Mental Health Nursing · doi:10.1080/01612840490274741 · Cited by 27 · see citing works

Suicide attempts in a prospective cohort of patients with schizophrenia treated with sertindole or risperidone

Crocq, M. A., Набер, Д., LADER, M. H., Thibaut, F., Drici, M., Everitt, B. J., Hall, G. C., Jeunne, C. L., Mittoux, A., Peuskens, J., et al. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.09.001 · Cited by 24 · see citing works

Effectiveness of Continuity-of-Care Programs to reduce time in hospital in persons with schizophrenia

Suárez, M. A., Bravo‐Ortiz, M. F., Fernández-Liria, A., & González-Juárez, C. (2011) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796011000138 · Cited by 22 · see citing works

Peer-counseling in schizophrenia: Patients consult patients

Rummel‐Kluge, C., Stiegler, M., Schwarz, C., Hansen, W., & Kissling, W. (2008) · Patient Education and Counseling · doi:10.1016/j.pec.2007.11.001 · Cited by 21 · see citing works

Schizophrenia

Marder, S. R., & Cannon, T. D. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1808803 · Cited by 533 · see citing works

The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia

Galderisi, S., Rossi, A., Rocca, P., Bertolino, A., Mucci, A., Bucci, P., Rucci, P., Gibertoni, D., Aguglia, E., Amore, M., et al. (2014) · World Psychiatry · doi:10.1002/wps.20167 · Cited by 464 · see citing works

Effectiveness, Core Elements, and Moderators of Response of Cognitive Remediation for Schizophrenia

Vita, A., Barlati, S., Ceraso, A., Nibbio, G., Ariu, C., Deste, G., & Wykes, T. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.0620 · Cited by 469 · see citing works

The COVID-19 Global Pandemic: Implications for People With Schizophrenia and Related Disorders

Kozloff, N., Mulsant, B. H., Stergiopoulos, V., & Voineskos, A. N. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa051 · Cited by 381 · see citing works

Interplay Among Psychopathologic Variables, Personal Resources, Context-Related Factors, and Real-life Functioning in Individuals With Schizophrenia

Galderisi, S., Rucci, P., Kirkpatrick, B. W., Mucci, A., Gibertoni, D., Rocca, P., Rossi, A., Bertolino, A., Strauss, G. P., Aguglia, E., et al. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.4607 · Cited by 311 · see citing works

The clinical characterization of the patient with primary psychosis aimed at personalization of management

Maj, M., van Os, J., De Hert, M., Gaebel, W., Galderisi, S., Green, M. F., Guloksuz, S., Harvey, P. D., Jones, P. B., Malaspina, D., et al. (2021) · World Psychiatry · doi:10.1002/wps.20809 · Cited by 285 · see citing works

Recovery from schizophrenia: is it possible?

Vita, A., & Barlati, S. (2018) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000407 · Cited by 187 · see citing works

Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses

Mucci, A., Galderisi, S., Gibertoni, D., Rossi, A., Rocca, P., Bertolino, A., Aguglia, E., Amore, M., Bellomo, A., Biondi, M., et al. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.4614 · Cited by 172 · see citing works

Community-based psychosocial interventions for people with schizophrenia in low and middle-income countries: systematic review and meta-analysis

Asher, L., Patel, V., & Silva, M. J. D. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1516-7 · Cited by 167 · see citing works

Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A Randomized, Multicenter, Double-Blind, Noninferiority Study

Savitz, A. J., Xu, H., Gopal, S., Nuamah, I. F., Ravenstijn, P. G. M., Janik, A., Schotte, A., Hough, D. W., & Fleischhacker, W. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw018 · Cited by 160 · see citing works

The interplay among psychopathology, personal resources, context‐related factors and real‐life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non‐recovered patients

Galderisi, S., Rucci, P., Mucci, A., Rossi, A., Rocca, P., Bertolino, A., Aguglia, E., Amore, M., Bellomo, A., Bozzatello, P., et al. (2020) · World Psychiatry · doi:10.1002/wps.20700 · Cited by 148 · see citing works

Bitopertin in Negative Symptoms of Schizophrenia—Results From the Phase III FlashLyte and DayLyte Studies

Bugarski‐Kirola, D., Blaettler, T., Arango, C., Fleischhacker, W., Garibaldi, G. M., Wang, A., Dixon, M., Bressan, R. A., Nasrallah, H. A., Lawrie, S. M., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.11.014 · Cited by 145 · see citing works

EEG-Based Measures in At-Risk Mental State and Early Stages of Schizophrenia: A Systematic Review

Perrottelli, A., Giordano, G. M., Brando, F., Giuliani, L., & Mucci, A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.653642 · Cited by 126 · see citing works

Social Cognitive Performance in Schizophrenia Spectrum Disorders Compared With Autism Spectrum Disorder

Oliver, L. D., Moxon‐Emre, I., Lai, M., Grennan, L., Voineskos, A. N., & Ameis, S. H. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.3908 · Cited by 115 · see citing works

Transforming the Treatment of Schizophrenia in the United States: The RAISE Initiative

Dixon, L. B., Goldman, H. H., Srihari, V. H., & Kane, J. M. (2018) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050817-084934 · Cited by 112 · see citing works

Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial

Durgam, S., Earley, W. R., Li, R., Li, D., Lu, K., Laszlovszky, I., Fleischhacker, W. W., & Nasrallah, H. A. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.06.030 · Cited by 103 · see citing works

The weaponization of medicine: Early psychosis in the Black community and the need for racially informed mental healthcare

Faber, S. C., Roy, A. K., Michaels, T. I., & Williams, M. T. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1098292 · Cited by 99 · see citing works

Wavelet transforms for feature engineering in EEG data processing: An application on Schizophrenia

Gosala, B., Kapgate, P. D., Jain, P., Chaurasia, R. N., & Gupta, M. (2023) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2023.104811 · Cited by 93 · see citing works

The Specific Level of Functioning Scale: construct validity, internal consistency and factor structure in a large Italian sample of people with schizophrenia living in the community.

Mucci, A., Rucci, P., Rocca, P., Bucci, P., Gibertoni, D., Merlotti, E., Galderisi, S., & Maj, M. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.07.044 · Cited by 95 · see citing works

A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale

Mucci, A., Vignapiano, A., Bitter, I., Austin, S. F., Delouche, C., Dollfus, S., Erfurth, A., Fleischhacker, W. W., Giordano, G. M., Олегович, Г. И., et al. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.05.006 · Cited by 85 · see citing works

Resilience, internalized stigma, self-esteem, and hopelessness among people with schizophrenia: Cultural comparison in Austria and Japan

Hofer, A., Mizuno, Y., Frajo-Apor, B., Kemmler, G., Suzuki, T., Pardeller, S., Welte, A.-S., Sondermann, C., Mimura, M., Wartelsteiner, F., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.01.027 · Cited by 83 · see citing works

Dopamine, the antipsychotic molecule: A perspective on mechanisms underlying antipsychotic response variability

Amato, D., Vernon, A. C., & Papaleo, F. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.09.027 · Cited by 80 · see citing works

Dysregulation of kynurenine pathway and potential dynamic changes of kynurenine in schizophrenia: A systematic review and meta-analysis.

Cao, B., Chen, Y., Ren, Z., Pan, Z., McIntyre, R., & Wang, D. (2021) · Neuroscience and Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.01.018 · Cited by 65 · see citing works

The Implementation of Evidence-Based Psychiatric Rehabilitation: Challenges and Opportunities for Mental Health Services

Vita, A., & Barlati, S. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00147 · Cited by 74 · see citing works

The Role of Brain Microvascular Endothelial Cell and Blood-Brain Barrier Dysfunction in Schizophrenia

Pong, S., Karmacharya, R., Sofman, M., Bishop, J. R., & Lizano, P. L. (2020) · Complex Psychiatry · doi:10.1159/000511552 · Cited by 71 · see citing works

Involvement of people with schizophrenia in decision-making in rural Ethiopia: a qualitative study

Souraya, S., Hanlon, C., & Asher, L. (2018) · Globalization and Health · doi:10.1186/s12992-018-0403-4 · Cited by 68 · see citing works

Improving Weight in People with Serious Mental Illness: The Effectiveness of Computerized Services with Peer Coaches

Young, A. S., Cohen, A. N., Goldberg, R. W., Hellemann, G., Kreyenbuhl, J., Niv, N., Nowlin-Finch, N., Oberman, R. S., & Whelan, F. (2017) · Journal of general internal medicine · doi:10.1007/s11606-016-3963-0 · Cited by 50 · see citing works

Antipsychotic-Induced Metabolic Syndrome: A Review

Akinola, S., Tardif, I., & Leclerc, J. (2023) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2023.0003 · Cited by 60 · see citing works

The enduring gap in educational attainment in schizophrenia according to the past 50 years of published research: a systematic review and meta-analysis

Crossley, N. A., Alliende, L. M., Czepielewski, L. S., Aceituno, D., Castañeda, C. P., Díaz, C., Iruretagoyena, B., Mena, C., Mena, C., Ramírez-Mahaluf, J. P., et al. (2022) · The Lancet Psychiatry · doi:10.1016/s2215-0366(22)00121-3 · Cited by 54 · see citing works

Value of schizophrenia treatment I: The patient journey

Mohr, P., Galderisi, S., Boyer, P., Wasserman, D., Arteel, P., Ieven, A., Kärkkäinen, H., Pereira, E., Guldemond, N., Winkler, P., et al. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2018.06.007 · Cited by 54 · see citing works

Social Recovery Therapy in improving activity and social outcomes in early psychosis: Current evidence and longer term outcomes

Fowler, D., Hodgekins, J., & French, P. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2017.10.006 · Cited by 53 · see citing works

Areas of interest and stigmatic attitudes of the general public in five relevant medical conditions: thematic and quantitative analysis using Twitter

Alvarez-Mon, M. A., Llavero-Valero, M., Sánchez-Bayona, R., Pereira-Sanchez, V., Vallejo-Valdivielso, M., Monserrat, J., Lahera, G., Asunsolo del Barco, A., & Alvarez-Mon, M. (2019) · Journal of Medical Internet Research · doi:10.2196/14110 · Cited by 52 · see citing works

Trends in big data analyses by multicenter collaborative translational research in psychiatry

Onitsuka, T., Hirano, Y., Nemoto, K., Hashimoto, N., Kushima, I., Koshiyama, D., Koeda, M., Takahashi, T., Noda, Y., Matsumoto, J., et al. (2021) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13311 · Cited by 49 · see citing works

Efficacy of oral versus long-acting antipsychotic treatment in patients with early-phase schizophrenia in Europe and Israel: a large-scale, open-label, randomised trial (EULAST)

Rossum, I. W.-V., Weiser, M., Galderisi, S., Leucht, S., Bitter, I., Glenthoj, B. Y., Hasan, A., Luykx, J. J., Kupchik, M., Psota, G., et al. (2023) · The Lancet Psychiatry · doi:10.1016/s2215-0366(23)00005-6 · Cited by 49 · see citing works

Psychosocial interventions in schizophrenia: Focus on guidelines

Ventriglio, A., Ricci, F., Magnifico, G., Chumakov, E. M., Torales, J. C., Watson, C. J., Castaldelli-Maia, J. M., Petito, A., & Bellomo, A. (2020) · International Journal of Social Psychiatry · doi:10.1177/0020764020934827 · Cited by 48 · see citing works

College students’ stigmatization of people with mental illness: familiarity, implicit person theory, and attribution

Lyndon, A. E., Crowe, A., Wuensch, K. L., McCammon, S. L., & Davis, K. B. (2016) · Journal of Mental Health · doi:10.1080/09638237.2016.1244722 · Cited by 45 · see citing works

Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment

Scheggia, D., Mastrogiacomo, R., Mereu, M., Sannino, S., Straub, R. E., Armando, M., Managò, F., Guadagna, S., Piras, F., Zhang, F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04711-w · Cited by 43 · see citing works

Mortality and suicide in schizophrenia: 21-year follow-up in rural China

Ran, M., Xiao, Y., Fazel, S., Lee, Y., Luo, W. P., Hu, S., Yang, X., Liu, B., Brink, M., Chan, S. K. W., et al. (2020) · BJPsych Open · doi:10.1192/bjo.2020.106 · Cited by 42 · see citing works

Mobile-Assisted Cognitive Behavioral Therapy for Negative Symptoms: Open Single-Arm Trial With Schizophrenia Patients

Granholm, E. L., Holden, J. L., Dwyer, K., Mikhael, T., Link, P. C., & Depp, C. A. (2020) · JMIR Mental Health · doi:10.2196/24406 · Cited by 40 · see citing works

Adipose tissue as a target for second-generation (atypical) antipsychotics: A molecular view

Ferreira, V., Grajales, D., & Valverde, Á. M. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.158534 · Cited by 39 · see citing works

Health and economic impacts of particulate matter pollution on hospital admissions for mental disorders in Chengdu, Southwestern China

Zhang, P., & Zhou, X. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.139114 · Cited by 37 · see citing works

Specialized Consultation for Suspected Recent-onset Schizophrenia: Diagnostic Clarity and the Distorting Impact of Anxiety and Reported Auditory Hallucinations

COULTER, C., Baker, K. K., & Margolis, R. L. (2019) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000363 · Cited by 33 · see citing works

Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques

Collo, G., Mucci, A., Giordano, G. M., Pich, E. M., & Galderisi, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00632 · Cited by 33 · see citing works

Periodontal Systemic Connections - Novel Associations : A Review of the Evidence with Implications for Medical Practitioners

Kalakonda, B., Koppolu, P., & Baroudi, K. (2016) · International Journal of Health Sciences · doi:10.12816/0048820 · Cited by 32 · see citing works

Psychosocial functioning in the balance between autism and psychosis: evidence from three populations

Abu-Akel, A. M., Wood, S. J., Upthegrove, R., Chisholm, K., Lin, A. P., Hansen, P., Gillespie, S. M., Apperly, I. A., & Montag, C. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01543-5 · Cited by 32 · see citing works

Improving Knowledge on Pathways to Functional Outcome in Schizophrenia: Main Results From the Italian Network for Research on Psychoses

Giuliani, L., Giordano, G. M., Bucci, P., Pezzella, P., Brando, F., & Galderisi, S. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.791117 · Cited by 29 · see citing works

Digital Technology for Caregivers of People With Psychosis: Systematic Review

Onwumere, J., Amaral, F., & Valmaggia, L. (2018) · JMIR Mental Health · doi:10.2196/mental.9857 · Cited by 27 · see citing works

Relationship between the timing of relapse and plasma drug levels following discontinuation of cariprazine treatment in patients with schizophrenia: indirect comparison with other second-generation antipsychotics after treatment discontinuation

Correll, C. U., Jain, R., Meyer, J. M., Periclou, A. P., Carrothers, T. J., Barabássy, Á., Patel, M., & Earley, W. R. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s210340 · Cited by 27 · see citing works

Prolactin and Thyroid Stimulating Hormone (TSH) Levels and Sexual Dysfunction in Patients with Schizophrenia Treated with Conventional Antipsychotic Medication: A Cross-Sectional Study

Zhang, Y., Tang, Z., Ruan, Y., Huang, C., Wu, J., Lu, Z., Li, W., Tang, Y., Liu, J., She, J., et al. (2018) · Medical Science Monitor · doi:10.12659/msm.913759 · Cited by 28 · see citing works

A naturalistic study on the relationship among resilient factors, psychiatric symptoms, and psychosocial functioning in a sample of residential patients with psychosis

Poloni, N., Zizolfi, D., Ielmini, M., Pagani, R., Caselli, I., Diurni, M., Milano, A., & Callegari, C. (2018) · Psychology Research and Behavior Management · doi:10.2147/prbm.s159571 · Cited by 26 · see citing works

The role of dopamine receptors in lymphocytes and their changes in schizophrenia

Penedo, M. A., Baltanás, T. R., Pérez-Rodríguez, D., Allen, J., Borrajo, A., Alonso-Crespo, D., Fernández-Pereira, C., Nieto-Araujo, M., Ramos-García, S., Barreiro-Villar, C., et al. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100199 · Cited by 26 · see citing works

Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature

Giordano, G. M., Brando, F., Pezzella, P., Angelis, M. D., Mucci, A., & Galderisi, S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.970210 · Cited by 26 · see citing works

Lactate levels in the brain and blood of schizophrenia patients: A systematic review and meta-analysis

Liu, S., Zhang, L., Fan, X., Wang, G., Liu, Q., Yang, Y., Shao, M., Song, M., Li, W., Lv, L., et al. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.11.013 · Cited by 26 · see citing works

Does Integrated Neurocognitive Therapy (INT) reduce severe negative symptoms in schizophrenia outpatients?

Mueller, D. R., Khalesi, Z., Benzing, V., Castiglione, C. I., & Roder, V. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.01.037 · Cited by 25 · see citing works

Changes in the Brain Extracellular Matrix Composition in schizophrenia: A Pathophysiological Dysregulation and a Potential Therapeutic Target

Rodrígues-Amorím, D., Baltanás, T. R., Fernández-Palleiro, P., Iglesias‐Martínez‐Almeida, M., Freiría‐Martínez, L., Rodríguez-Jamardo, C., Vallejo-Curto, M. D. C., Álvarez-Ariza, M., López-García, M., Heras, E. D. L., et al. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01073-8 · Cited by 23 · see citing works

Repetitive Transcranial Magnetic Stimulation as a Therapeutic and Probe in Schizophrenia: Examining the Role of Neuroimaging and Future Directions

Brandt, S. J., Oral, H. Y., Arellano-Bravo, C., Plawecki, M. H., Hummer, T. A., & Francis, M. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01046-1 · Cited by 23 · see citing works

Risperidone-Induced Adverse Drug Reactions and Role of DRD2 (−141 C Ins/Del) and 5HTR2C (−759 C>T) Genetic Polymorphisms in Patients with Schizophrenia

Goud, A. C., Mohan, A., Shewade, D. G., Rajkumar, R. P., Adithan, C., & Subramanian, K. (2017) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/jpp.jpp_197_16 · Cited by 22 · see citing works

Treatment of Cognitive Impairment Associated with Schizophrenia Spectrum Disorders: New Evidence, Challenges, and Future Perspectives

Calzavara‐Pinton, I., Nibbio, G., Barlati, S., Bertoni, L., Necchini, N., Zardini, D., Baglioni, A., Paolini, S., Poddighe, L., Bulgari, V., et al. (2024) · Brain Sciences · doi:10.3390/brainsci14080791 · Cited by 23 · see citing works

Schizophrenia and “unmet needs”: From diagnosis to care in Italy

Galderisi, S., Riva, M. A., Girardi, P., Amore, M., Carpiniello, B., Aguglia, E., Fagiolini, A. M., Mucci, A., & Vita, A. (2020) · European Psychiatry · doi:10.1192/j.eurpsy.2019.8 · Cited by 21 · see citing works

The transition from adolescence to adulthood in patients with schizophrenia: Challenges, opportunities and recommendations

Arango, C., Buitelaar, J. K., Correll, C. U., Díaz‐Caneja, C. M., Figueira, M. L., Fleischhacker, W. W., Marcotulli, D., Parellada, M., & Vitiello, B. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.04.005 · Cited by 21 · see citing works

Eficacia, eficiencia y efectividad en el tratamiento multidimensional de la esquizofrenia: proyecto Rethinking

Crespo‐Facorro, B., Bernardo, M., Argimón, J. M., Arrojo, M., Bravo‐Ortiz, M. F., Cabrera-Cifuentes, A., Román, J. C., Franco, M., García‐Portilla, M. P., Haro, J. M., et al. (2016) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2016.09.001 · Cited by 21 · see citing works

Functional benefits of co-occurring autistic symptoms in schizophrenia is delimited by symptom severity

Bechi, M., Abu-Akel, A. M., Agostoni, G., Bosia, M., Cocchi, F., Spangaro, M., & Cavallaro, R. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.02.044 · Cited by 20 · see citing works

Measuring Users’ Receptivity Toward an Integral Intervention Model Based on mHealth Solutions for Patients With Treatment-Resistant Schizophrenia (m-RESIST): A Qualitative Study

Huerta-Ramos, E., Escobar-Villegas, M. S., Rubinstein, K., Unoka, Z. S., Grasa, E., Hospedales, M., Jääskeläinen, E., Rubio-Abadal, E., Caspi, A., Bitter, I., et al. (2016) · JMIR mHealth and uHealth · doi:10.2196/mhealth.5716 · Cited by 20 · see citing works

Association of rs4680 COMT, rs6280 DRD3, and rs7322347 5HT2A With Clinical Features of Youth-Onset Schizophrenia

Morozova, A. Y., Zorkina, Y., Ka, P., Pavlova, O., Storozheva, Z. I., Zubkov, E. A., Zakharova, N. V., Karpenko, O., Reznik, A. M., Chekhonin, V. P., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00830 · Cited by 20 · see citing works

Investigating the shared genetic architecture between schizophrenia and body mass index

Yu, Y., Fu, Y., Yu, Y., Tang, M., Sun, Y., Wang, Y., Zhang, K., Li, H., Guo, H., Wang, B., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02104-0 · Cited by 19 · see citing works

Cognitive, creative, functional, and clinical symptom improvements in schizophrenia after an integrative cognitive remediation program: a randomized controlled trial

Sampedro, A., Peña, J., Sánchez, P., Ibarretxe‐Bilbao, N., Gómez‐Gastiasoro, A., Iriarte‐Yoller, N., Pavón, C., Tous‐Espelosin, M., & Ojeda, N. (2021) · Schizophrenia · doi:10.1038/s41537-021-00181-0 · Cited by 19 · see citing works

Trajectories of patients with severe mental illness in two-year contact with Flexible Assertive Community Treatment teams using Routine Outcome Monitoring data: An observational study

Kortrijk, H. E., Schaefer, B., van Weeghel, J., Mulder, C. L., & Kamperman, A. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0207680 · Cited by 16 · see citing works

Transcranial direct current stimulation for auditory verbal hallucinations: a systematic review of clinical trials

Hao, Y., Yadollahpour, A., Rashidi, S., Jones, M., Murillo‐Rodríguez, E., & Machado, S. E. D. C. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.295315 · Cited by 16 · see citing works

Medication adherence, healthcare resource utilization, and costs among Medicaid beneficiaries with schizophrenia treated with once-monthly paliperidone palmitate or once-every-three-months paliperidone palmitate

Lin, D., Pilon, D., Zhdanava, M., Joshi, K., Lafeuille, M., Côté‐Sergent, A., Vermette-Laforme, M., & Lefèbvre, P. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1882412 · Cited by 16 · see citing works

Clinical insight and cognitive functioning as mediators in the relationships between symptoms of psychosis, depression, and suicide ideation in first-episode psychosis

Bornheimer, L. A., Cobia, D. J., Verdugo, J. L., Holzworth, J., & Smith, M. J. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.01.006 · Cited by 15 · see citing works

Effectiveness of sensory modulation for people with schizophrenia: A multisite quantitative prospective cohort study

Machingura, T., Shum, D., Lloyd, C., Murphy, K. A., Rathbone, E. N., & Green, H. J. (2022) · Australian Occupational Therapy Journal · doi:10.1111/1440-1630.12803 · Cited by 15 · see citing works

Associations of C-Reactive Protein, Free Triiodothyronine, Thyroid Stimulating Hormone and Creatinine Levels with Agitation in Patients with Schizophrenia: A Comparative Cross-Sectional Study

Li, C., Shi, Z., Ji, J., Niu, G., & Liu, Z. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s322005 · Cited by 15 · see citing works

Mismatch Negativity and P3a Impairment through Different Phases of Schizophrenia and Their Association with Real-Life Functioning

Giordano, G. M., Giuliani, L., Perrottelli, A., Bucci, P., Lorenzo, G. D., Siracusano, A., Brando, F., Pezzella, P., Fabrazzo, M., Altamura, M., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245838 · Cited by 15 · see citing works

Integrated treatment of schizophrenia

Altamura, A. C., Fagiolini, A. M., Galderisi, S., Rocca, P., & Rossi, A. (2015) · Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" · Cited by 15 · see citing works

Sleep disturbances are associated with psychosis in schizophrenia spectrum Disorders: An umbrella review

Azargoonjahromi, A., & Bahrampour, Z. (2025) · Sleep Medicine · doi:10.1016/j.sleep.2025.106690 · Cited by 17 · see citing works

Psychiatric and non-psychiatric polypharmacy among older adults with schizophrenia: Trends from a population-based study between 2000 and 2016

Lunghi, C., Rochette, L., Massamba, V. K., Tardif, I., Ouali, A., & Sirois, C. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1080073 · Cited by 15 · see citing works

Lowered serum cesium levels in schizophrenia: association with immune-inflammatory biomarkers and cognitive impairments

Almulla, A. F., Moustafa, S. R., Al-Dujaili, A. H., Al‐Hakeim, H. K., & Maes, M. H. J. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2020-0908 · Cited by 14 · see citing works

Effect of individualized occupational therapy on social functioning in patients with schizophrenia: A five-year follow-up of a randomized controlled trial

Shimada, T., Inagaki, Y., Shimooka, Y., Kawano, K., Tanaka, S., & Kobayashi, M. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.10.066 · Cited by 14 · see citing works

The Effect of Accelerated Continuous Theta Burst Stimulation on Weight Loss in Overweight Individuals With Schizophrenia: A Double-Blind, Randomized, Sham-Controlled Clinical Trial

Kang, D., Zhang, Y., Wu, G., Song, C., Peng, X., Long, Y., Guo, Y., Tang, H., Gui, Y., Wang, Q., et al. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad144 · Cited by 13 · see citing works

System biology approaches to identify hub genes linked with ECM organization and inflammatory signaling pathways in schizophrenia pathogenesis

Bhuiyan, P., Sun, Z., Khan, M. A., Hossain, M. A., Rahman, M. H., & Qian, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e25191 · Cited by 14 · see citing works

“Being There” vs “Being Direct:” Perspectives of Persons with Serious Mental Illness on Receiving Support with Physical Health from Peer and Non-Peer Providers

Bochicchio, L. A., Stefancic, A., Mctavish, C., Tuda, D., & Cabassa, L. (2021) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-020-01098-z · Cited by 9 · see citing works

Effectiveness, efficiency and efficacy in the multidimensional treatment of schizophrenia: Rethinking project

Crespo‐Facorro, B., Bernardo, M., Argimón, J. M., Arrojo, M., Bravo‐Ortiz, M. F., Cabrera-Cifuentes, A., Román, J. C., Franco, M., García‐Portilla, M. P., Haro, J. M., et al. (2017) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2016.09.002 · Cited by 13 · see citing works

Unveiling Promising Neuroimaging Biomarkers for Schizophrenia Through Clinical and Genetic Perspectives

Guo, J., He, C.-Y., Song, H., Gao, H., Yao, S., Dong, S., & Yang, T. (2024) · Neuroscience Bulletin · doi:10.1007/s12264-024-01214-1 · Cited by 12 · see citing works

Genetic aspects of schizophrenia

Morozova, A. Y., Zubkov, E. A., Zorkina, Y., Reznik, A. M., Kostyuk, G. P., & Chekhonin, V. P. (2017) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201711761126-132 · Cited by 12 · see citing works

Factors that Affect Choice of Mental Health Provider and Receipt of Outpatient Mental Health Treatment

Jones, J. M., Ali, M. M., Mutter, R. L., Henke, R. M., Gokhale, M., Marder, W. D., & Mark, T. L. (2017) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-017-9575-6 · Cited by 12 · see citing works

The effect of continuous theta burst stimulation on antipsychotic-induced weight gain in first-episode drug-naive individuals with schizophrenia: a double-blind, randomized, sham-controlled feasibility trial

Kang, D., Song, C., Peng, X., Guo, Y., Yang, Y., Chen, C., Long, Y., Shao, P., & Wu, R. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02770-w · Cited by 12 · see citing works

DHF-7 Ameliorates Behavioral Disorders and White Matter Lesions by Regulating BDNF and Fyn in a Mouse Model of Schizophrenia Induced by Cuprizone and MK-801

Sun, Z., Ma, D., Gu, L.-H., Chen, X., Zhang, L., & Li, L. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac022 · Cited by 11 · see citing works

Efficacy, safety, and tolerability of xanomeline for schizophrenia spectrum disorders: a systematic review

Leber, A., Ramachandra, R., Ceban, F., Kwan, A. T. H., Rhee, T. G., Wu, J., Cao, B., Jawad, M. Y., Teopiz, K. M., Ho, R., et al. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2334424 · Cited by 11 · see citing works

Trial-Based Economic Evaluations of Supported Employment for Adults with Severe Mental Illness: A Systematic Review

Zheng, K., Stern, B. Z., Wafford, Q. E., & Kohli-Lynch, C. N. (2022) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-021-01174-y · Cited by 11 · see citing works

Is It Possible to Combine Non-Invasive Brain Stimulation and Evidence-Based Psychosocial Interventions in Schizophrenia? A Critical Review

Lisoni, J., Nibbio, G., Baglioni, A., Dini, S., Manera, B., Maccari, A., Altieri, L., Calzavara‐Pinton, I., Zucchetti, A., Deste, G., et al. (2024) · Brain Sciences · doi:10.3390/brainsci14111067 · Cited by 10 · see citing works

Progress in mechanistically novel treatments for schizophrenia

Neef, J., & Palacios, D. S. (2021) · RSC Medicinal Chemistry · doi:10.1039/d1md00096a · Cited by 10 · see citing works

Employment-Related Factors of Forensic Psychiatric Outpatients with Psychotic Disorders

Takeda, K., Sugawara, N., Yamada, Y., Nagata, T., Kashiwagi, H., Kono, T., Hirabayashi, N., & Okada, T. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s228916 · Cited by 10 · see citing works

Effect of Computer-Assisted Cognitive Remediation Therapy on Cognition among Patients with Schizophrenia: A Pilot Randomized Controlled Trial

Yamanushi, A., Shimada, T., Koizumi, A., & Kobayashi, M. (2024) · Biomedicines · doi:10.3390/biomedicines12071498 · Cited by 9 · see citing works

Investigating the causal pathways among psychopathological variables, cognitive impairment, and real-life functioning in people with schizophrenia

Giuliani, L., Sanmarchi, F., Mucci, A., Rucci, P., Caporusso, E., Bucci, P., Giordano, G. M., Amore, M., Rocca, P., Rossi, A., et al. (2025) · Schizophrenia · doi:10.1038/s41537-024-00545-2 · Cited by 9 · see citing works

Real-World Functioning in Psychiatric Outpatients: Predictive Factors

Bozzatello, P., Giordano, B., Montemagni, C., Rocca, P., & Bellino, S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154400 · Cited by 9 · see citing works

Altered functional dynamics gradient in schizophrenia with cigarette smoking

Chen, Y. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad030 · Cited by 9 · see citing works

Discovery of novel arylpiperazine-based DA/5-HT modulators as potential antipsychotic agents – Design, synthesis, structural studies and pharmacological profiling

Stępnicki, P., Targowska‐Duda, K. M., Martínez, A. L., Zięba, A., Wronikowska‐Denysiuk, O., Wróbel, M. Z., Bartyzel, A., Trzpil, A., Wróbel, T. M., Chodkowski, A., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115285 · Cited by 8 · see citing works

Inflammatory markers in outpatients with schizophrenia diagnosis in regular use of clozapine: a cross-sectional study

Cordova, V., Teixeira, A. D., Anzolin, A. P., Moschetta, R., & Belmonte-de-Abreu, P. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1269322 · Cited by 8 · see citing works

Effect of individualized occupational therapy on cognition among patients with schizophrenia: A randomized controlled trial

Shimada, T., Morimoto, T., Nagayama, H., Nakamura, N., Aisu, K., Kito, A., Kojima, R., Yamanushi, A., Kawano, K., Hikita, N., et al. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.04.018 · Cited by 8 · see citing works

EPA-0678 - Schizophrenia and public health

Sartorius, N. (2014) · European Psychiatry · doi:10.1016/s0924-9338(14)78045-9

Rethinking Schizophrenia: Beyond the Voices of Schizophrenia

Suchoňová, D., & Kéri, P. (2024) · European Psychiatry · doi:10.1192/j.eurpsy.2024.1585 · Cited by 1 · see citing works

The 2016 RANZCP Guidelines for the Management of Schizophrenia and Related Disorders – what’s next?

Jablensky, A. V., Castle, D. J., Dark, F. L., Humberstone, V., Killackey, E. J., Kulkarni, J., McGorry, P. D., Morgan, V. A., Nielssen, O. B., Tran, N., et al. (2017) · Australasian Psychiatry · doi:10.1177/1039856217726691 · Cited by 7 · see citing works

Value of schizophrenia treatment I: The patient journey

Mohr, P., Galderisi, S., Boyer, P., Wasserman, D., Arteel, P., Ieven, A., Kärkkäinen, H., Pereira, E., Guldemond, N., Winkler, P., et al. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2018.06.007 · Cited by 54 · see citing works

Treatment Outcomes in Schizophrenia: Implications for Practice, Policy, and Research

Lehman, A. F., Carpenter, W. T., Goldman, H. H., & Steinwachs, D. M. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.669 · Cited by 97 · see citing works